Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report
Open Access
- 9 August 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27824
Abstract
Idiopathic inflammatory myopathies (IIMs) are a group of chronic autoimmune disorders characterized by proximal skeletal muscle weakness. One subtype of the IIMs is immune-mediated necrotizing myopathy (IMNM). IMNM can be further classified according to its autoantibody presence, including anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), anti-signal recognition particle (SRP), and seronegative. Here, we describe the case of a 61-year-old Caucasian female with a prior history of distant lung cancer and current statin use presenting with a subacute onset of bilateral proximal lower extremity muscle weakness and markedly elevated creatinine kinase (CK) and amino transaminases. In the acute inpatient setting, she underwent successful treatment with corticosteroids that were eventually discontinued and replaced with azathioprine three months after hospital admission. At that point, she had attained a 60% increase in muscle strength.Keywords
This publication has 18 references indexed in Scilit:
- Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition ParticleArthritis Care & Research, 2016
- High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibodyBrain, 2016
- Intravenous Immune Globulin for Statin-Triggered Autoimmune MyopathyNew England Journal of Medicine, 2015
- Treatment of inflammatory myopathy: emerging therapies and therapeutic targetsExpert Review of Clinical Immunology, 2015
- Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patientsOrphanet Journal of Rare Diseases, 2015
- Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysisBMC Musculoskeletal Disorders, 2012
- Usefulness of anti‐p155 autoantibody for diagnosing cancer‐associated dermatomyositis: A systematic review and meta‐analysisArthritis & Rheumatism, 2011
- Diagnosis and treatment of the idiopathic inflammatory myopathiesTherapeutic Advances in Musculoskeletal Disease, 2011
- Immune‐mediated necrotizing myopathy associated with statinsMuscle & Nerve, 2009
- Paraneoplastic necrotizing myopathyNeurology, 1998